External Liver Assist Product
Pre-clinical- Indications
- Acute liver failure
Company intelligence / Profile preview
The company’s InSet™ technology has demonstrated significant reduction in glenoid implant micro-motion and improved long-term stability. Clinical results show reduced risk of revision surgery due to glenoid loosening, with simplified surgical technique and enhanced patient outcomes. The portfolio includes anatomic and reverse total shoulder systems as well as a newly cleared stemless option.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shoulder Innovations.